Belgium vs Sweden: Proportion of isolates with resistance to azithromycin reported to
Belgium
17.6
in 2020
Sweden
22
in 2020
Belgium rank
7th
Sweden rank
5th
Proportion of isolates with resistance to azithromycin reported to over time
- Belgium
- Sweden
How they compare
Sweden currently reports 22 against 17.6 in Belgium, a difference of 4.4.
That makes Sweden's figure about 1.2 times Belgium's.
The two have swapped places 3 times across 11 shared years of data; in 2009 it was Belgium ahead.
Belgium ranks 7th and Sweden ranks 5th of 47 countries.
Across the 3 decades both report, Belgium averaged higher in 1 and Sweden in 2.
Head to head by decade
| Decade | Belgium | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.55 | 10.19 | 4.36 | Belgium |
| 2010s | 5.82 | 5.91 | 0.0948 | Sweden |
| 2020s | 17.6 | 22 | 4.4 | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with resistance to azithromycin reported to, Belgium or Sweden?
- Sweden, at 22 against 17.6 in Belgium as of 2020.
- What is the difference in proportion of isolates with resistance to azithromycin reported to between Belgium and Sweden?
- 4.4, with Sweden ahead.
- How many years of comparable data are there for Belgium and Sweden?
- 11 years are reported by both, from 2009 to 2020.
- How do Belgium and Sweden rank globally for proportion of isolates with resistance to azithromycin reported to?
- Belgium ranks 7th and Sweden ranks 5th of 47 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with resistance to azithromycin reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.